业聚医疗 06929Stock Information

Stock Information · Old Rules
// Company Overview //
Stock Name业聚医疗
Stock Code06929
Company Full Name业聚医疗
Industry醫療保健
Principal Activities主要從事設計、開發、制造及銷售用於治療冠狀動脈及外周血管疾病的醫療器械。
Listing Date2022-12-23
Listing Rules EraOld Rules
Listing Rules ChapterNo data
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港新界沙田香港科學園20E號樓3樓303室和305室
Business Address (Hong Kong)No data
Place of IncorporationNo data
Listing MethodNo data
Listing BoardMain Board
Websitehttps://orbusneich.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
// Offering Information //
Offering Mechanism 未知
Clawback TiersNo data
Prospectus Date2022-12-13
Offer PriceHK$ 8.80 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 4,400
Par ValueNo data
Global Offering Shares
HK Public Offering Shares— (0%)
International Placing Shares— (0%)
Offer RatioNo data
Total Shares Post-IPONo data
Total Global Offering SizeHK$ —
Public Offering SizeHK$ — (0%)
Oversubscription Multiple—x
Valid Applications
Accepted Applications
ReallocationNo
Total Funds RaisedHK$ 48,083,200
Greenshoe (Over-allotment Option)No data
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 0
Pre-IPO Valuation (Last Round)No data
P/E Ratio-209.03
Profit/Loss StatusNo data
Period-End Cash BalanceNo data
Listing Expenses~HK$ 114,000,000
Listing Expenses / Funds RaisedNo data
Total Pre-IPO InvestmentNo data
// First Day Performance
First Day CloseLoading...
First Day OpenHK$ 8.8
First Day Change3.98%
First Day Volume4592500.0
First Day Turnover40174300.0
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds1、30.0%(或約110.0百萬港元)分配予在研產品開發及商業化; 2、54.2%(或約198.8百萬港元)被分配用于擴大我們的產能; 3、10.8%(或約39.7百萬港元)用于為潛在戰略收購、建立戰略合作伙伴關系及其他業務發展提供資金; 4、5.0%(或約18.3百萬港元)用作營運資金及用于其他一般企業事項。
// Underwriting Syndicate //
联席保荐人 (2)
中国国际金融香港证券有限公司 建银国际金融有限公司
整体协调人 (5)
中国国际金融香港证券有限公司 建银国际金融有限公司 法国巴黎证券(亚洲)有限公司 中信里昂证券有限公司 招商证券(香港)有限公司
联席账簿管理人 (8)
中国国际金融香港证券有限公司 建银国际金融有限公司 法国巴黎证券(亚洲)有限公司 中信里昂证券有限公司 招商证券(香港)有限公司 中募金融资管有限公司 富途证券国际(香港)有限公司 越秀证券有限公司
联席牵头经办人 (8)
中国国际金融香港证券有限公司 建银国际金融有限公司 法国巴黎证券(亚洲)有限公司 中信里昂证券有限公司 招商证券(香港)有限公司 中募金融资管有限公司 富途证券国际(香港)有限公司 越秀证券有限公司
// Cornerstone Investors //
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 杭州富阳产业基金投资管理有限公司 313,997,200 HKD 65.31% 6 months 2023-06-23
// Directors & Management //
Chairman錢永勛
Company Secretary陳泳成
No director data available.
// Major Shareholders //
Major Shareholders & Holdings錢永勛及家族成員(63.00%);深圳市創新投資集團有限公司(11.84%)
// Allotment Benchmarks //
Pool A (Small Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
500 2,589 2,589 0.46
1,000 550 550 0.92
1,500 110 110 1.38
2,000 99 99 1.84
2,500 117 117 2.29
3,000 59 59 2.75
3,500 18 18 3.17
4,000 51 51 3.61
4,500 17 17 4.06
5,000 114 114 4.51
6,000 28 28 5.39
7,000 12 12 6.25
8,000 10 10 7.10
9,000 7 7 7.86
10,000 67 67 8.72
15,000 20 20 13.05
20,000 20 20 17.40
25,000 16 16 21.75
30,000 11 11 26.09
35,000 1 1 30.00
40,000 2 2 34.00
45,000 3 3 38.00
50,000 6 6 42.00
60,000 1 1 50.00
70,000 2 2 58.00
80,000 4 4 66.00
90,000 1 1 74.00
100,000 8 8 82.00
200,000 3 3 164.00
250,000 1 1 205.00
400,000 1 1 328.00
500,000 1 1 410.00
Pool B (Large Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
600,000 2 2 1200.00
Allotment Benchmarks
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics